$75.05
-1.05-1.38%
In chiusura: Nov 19, 4:00 PM EST
$75.36
0.310.42%
Pre-mercato: 4:32 AM EST
Corcept Therapeutics fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/04/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $800.00M | $850.00M | $852.50M | |
07/31/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $850.00M | $900.00M | $899.04M | |
05/05/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $905.38M | |
02/26/2025 | CORT | Corcept Therapeutics | FY | 2025 | — | — | — | $900.00M | $950.00M | $855.08M | |
10/30/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $675.00M | $700.00M | $661.06M | |
07/29/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $640.00M | $670.00M | $632.15M | |
05/01/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $620.00M | $650.00M | $610.64M | |
02/15/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $531.57M | |
01/08/2024 | CORT | Corcept Therapeutics | Q4 | 2023 | — | — | — | $135.40M | $135.40M | $127.85M | |
01/08/2024 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $482.40M | $482.40M | $474.82M | |
01/08/2024 | CORT | Corcept Therapeutics | FY | 2024 | — | — | — | $600.00M | $630.00M | $513.85M | |
11/01/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $470.00M | $480.00M | $465.62M | |
08/02/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $455.00M | $470.00M | $443.89M | |
05/03/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $435.00M | $455.00M | $435.73M | |
02/28/2023 | CORT | Corcept Therapeutics | FY | 2023 | — | — | — | $430.00M | $450.00M | $434.79M | |
11/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $410.00M | $416.67M | |
08/03/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $414.43M | |
05/05/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.85M | |
02/15/2022 | CORT | Corcept Therapeutics | FY | 2022 | — | — | — | $400.00M | $430.00M | $413.19M |
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Corcept Therapeutics.
Sfoglia guidance e previsioni su tutte le azioni.